Spermatogenesis-associated protein 31A3 (SPATA31A3)

Spermatogenesis-associated protein 31A3 (SPATA31A3) is a predicted membrane-associated protein that may play a role in the process of spermatogenesis and cell differentiation, as inferred from expression profiling and bioinformatic prediction[1][3][5]. It is part of the FAM75 protein family and has several paralogs within the human genome. This protein has not been characterized as a receptor, enzyme, or other classic drug target, and its biological function is not fully delineated beyond expression association with spermatogenic tissue. Disease links are suggestive rather than definitive and do not demonstrate causal mechanisms. No current drugs, biomarker roles, or safety issues are reported for this molecule. SPATA31A3 is not currently considered a druggable therapeutic target. Its canonical name and abbreviation are well established in human gene nomenclature. The most notable biological association is with spermatogenesis, but broader functional characterization is lacking. There are no known chemical or drug interactions, nor is it established as a biomarker for any clinical use[1][5].

Other names

SPATA31A3FAM75A3DKFZp434B204OTTHUMG00000013164Protein FAM75A3Family with sequence similarity 75, member A3

Not applicable; there are no known drugs targeting this protein